These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 37515334)
1. [IgG Fc binding protein (FCGBP) as a prognostic marker of low-grade glioma and its correlation analysis with immune infiltration]. Liu Q; Zhang J; Zhang F; Zhang W; Gong L Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Aug; 39(8):686-692. PubMed ID: 37515334 [TBL] [Abstract][Full Text] [Related]
2. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma. Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355 [TBL] [Abstract][Full Text] [Related]
3. SYT16 is a prognostic biomarker and correlated with immune infiltrates in glioma: A study based on TCGA data. Chen J; Wang Z; Wang W; Ren S; Xue J; Zhong L; Jiang T; Wei H; Zhang C Int Immunopharmacol; 2020 Jul; 84():106490. PubMed ID: 32289666 [TBL] [Abstract][Full Text] [Related]
4. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma. Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A Front Genet; 2021; 12():718717. PubMed ID: 34925438 [No Abstract] [Full Text] [Related]
5. FCGBP Is a Prognostic Biomarker and Associated With Immune Infiltration in Glioma. Yan T; Tian D; Chen J; Tan Y; Cheng Y; Ye L; Deng G; Liu B; Yuan F; Zhang S; Cai L; Chen Q Front Oncol; 2021; 11():769033. PubMed ID: 35047393 [TBL] [Abstract][Full Text] [Related]
6. CKS2 (CDC28 protein kinase regulatory subunit 2) is a prognostic biomarker in lower grade glioma: a study based on bioinformatic analysis and immunohistochemistry. Hu M; Li Z; Qiu J; Zhang R; Feng J; Hu G; Ren J Bioengineered; 2021 Dec; 12(1):5996-6009. PubMed ID: 34494924 [TBL] [Abstract][Full Text] [Related]
7. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma. Hao YP; Wang WY; Qiao Q; Li G Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884 [TBL] [Abstract][Full Text] [Related]
8. A Novel Prognostic Marker and Therapeutic Target Associated with Glioma Progression in a Tumor Immune Microenvironment. Zhang JJ; Zhang Y; Chen Q; Chen QN; Yang X; Zhu XL; Hao CY; Duan HB J Inflamm Res; 2023; 16():895-916. PubMed ID: 36883185 [TBL] [Abstract][Full Text] [Related]
9. Development and validation of a leukocyte-associated immunoglobulin-like receptor-1 prognostic signature for lower-grade gliomas. Fang Z; Lin L; Tu Z; Zhu X; Li J; Luo P; Huang K; Wu L Cancer Med; 2023 Jan; 12(1):712-732. PubMed ID: 35702880 [TBL] [Abstract][Full Text] [Related]
10. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy. Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057 [TBL] [Abstract][Full Text] [Related]
11. DNALI1 is a prognosis-related biomarker and correlates with immune infiltrates in low grade glioma. Lu Y; Chang P; Bian J; Zhu L Cancer Biomark; 2023; 38(3):393-407. PubMed ID: 37955080 [TBL] [Abstract][Full Text] [Related]
12. TUBA1C is a Prognostic Marker in Low-grade Glioma and Correlates with Immune Cell Infiltration in the Tumor Microenvironment. Zhu H; Hu X; Gu L; Jian Z; Li L; Hu S; Qiu S; Xiong X Front Genet; 2021; 12():759953. PubMed ID: 34721547 [TBL] [Abstract][Full Text] [Related]
13. PTPRN Serves as a Prognostic Biomarker and Correlated with Immune Infiltrates in Low Grade Glioma. Li P; Chen F; Yao C; Zhu K; Zhang B; Zheng Z Brain Sci; 2022 Jun; 12(6):. PubMed ID: 35741647 [TBL] [Abstract][Full Text] [Related]
14. A bioinformatic analysis: the overexpression and clinical significance of FCGBP in ovarian cancer. Wang K; Guan C; Shang X; Ying X; Mei S; Zhu H; Xia L; Chai Z Aging (Albany NY); 2021 Mar; 13(5):7416-7429. PubMed ID: 33686968 [TBL] [Abstract][Full Text] [Related]
15. MCM10 as a novel prognostic biomarker and its relevance to immune infiltration in gliomas. Tian QS; Zhang Q; Huang W Technol Health Care; 2023; 31(4):1301-1317. PubMed ID: 36872806 [TBL] [Abstract][Full Text] [Related]
16. Correlation between ITGB2 expression and clinical characterization of glioma and the prognostic significance of its methylation in low-grade glioma(LGG). Liu H; Wang J; Luo T; Zhen Z; Liu L; Zheng Y; Zhang C; Hu X Front Endocrinol (Lausanne); 2022; 13():1106120. PubMed ID: 36714574 [TBL] [Abstract][Full Text] [Related]
17. Elevated expression of mitochondrial transcription elongation factor (TEFM) predicts poor prognosis in low grade glioma-an analysis of the Cancer Genome Atlas (TCGA) dataset. Li S; Wang W; Zi J; Sun M; Mei W; Yang N; Zhang R; Yu M; Xiong W Transl Cancer Res; 2020 May; 9(5):3610-3622. PubMed ID: 35117724 [TBL] [Abstract][Full Text] [Related]
18. Next-generation sequencing identifies HOXA6 as a novel oncogenic gene in low grade glioma. Xiulin J; Wang C; Guo J; Wang C; Pan C; Nie Z Aging (Albany NY); 2022 Mar; 14(6):2819-2854. PubMed ID: 35349479 [TBL] [Abstract][Full Text] [Related]
19. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma. Zhang M; Wang X; Chen X; Zhang Q; Hong J Front Genet; 2020; 11():363. PubMed ID: 32351547 [TBL] [Abstract][Full Text] [Related]
20. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma. Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]